SysKid stands for »Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment«. The project has started on Jan 1, 2010 and is driven by a European Union grant of EUR 11,8 million from Framework Programme 7 (FP 7) and a total project volume of close to EUR 16 million. The consortium consists of 26 research groups from 15 countries. Runtime of the project is scheduled for five years.
read more » Syskid-Folder
SysKid integrates a balanced mix of clinicians, statisticians, epidemiologists, molecular researchers and bioinformaticians from universities, small- and medium-sized enterprises as well as industry partners.
» More about our research groups
Dr. Bernd Mayer, Managing Partner of emergentec biodevelopment GmbH, serves the consortium as overall project coordinator. Eight researchers from different SysKid research groups are members of the management team.
Leading experts in basic and applied research are members of SysKid’s advisory board. This prestigious setting assures top level coverage of the project and contributes to SysKid’s success.
Following a state-of-the-art Systems Biology approach, SysKid establishes a comprehensive picture of the consequences of diabetes and hypertension on kidney function. SysKid focuses on the early stage of chronic kidney disease and aims at identifying better strategies for prevention as well as novel diagnosis and therapy options.
SysKid | A Collaborative FP7 Research Project to Fight Chronic Kidney Disease
This project is supported through European Union's FP7,
Grant agreement number HEALTH–F2–2009–241544